Trials / Completed
CompletedNCT05090683
Evaluation of a Mind-body Based Application for the Treatment of Chronic/Persistent Pain.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 198 (actual)
- Sponsor
- University of the Fraser Valley · Academic / Other
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
We are investigating the effects of a mind-body based mobile application on the experience of chronic pain. Participants meeting our criteria for chronic pain (confirmed via self-report) will complete an online baseline questionnaire. Eligible participants will be enrolled in the study and randomized into control (usual care, waitlisted) or intervention group (6-week mind-body based mobile application intervention). Randomization will be stratified by pain intensity and gender using computer-generated block randomization to create varying block sizes of 4 and 8. We will run the trial in multiple cohorts in series to obtain desired sample size. All participants will complete online questionnaires at baseline and post-intervention at 6 weeks that measure pain intensity, interference with daily living, pain perceptions, mental health outcomes, and medication use. Participants will also complete weekly questionnaires on weeks 2 to 6 to gauge frequency of application usage (intervention) or other pain treatments (control). Participants in the intervention group will be asked to repeat the follow-up questionnaire at 12-weeks.
Detailed description
See protocol for more details. (submitted at time of registration)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mind-body mobile application | Self-directed; Study team will recommend daily use of mobile app for 6 weeks with a minimum of 4 times/week usage of mobile app for 6 weeks. Frequency will be monitored via weekly surveys. |
Timeline
- Start date
- 2021-10-15
- Primary completion
- 2022-06-15
- Completion
- 2022-07-15
- First posted
- 2021-10-25
- Last updated
- 2025-01-29
- Results posted
- 2025-01-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05090683. Inclusion in this directory is not an endorsement.